LabCompass

Ekta Verma

Chemistry · Indiana University

OpenAlex ORCID
Synthesis and biological activityQuinazolinone synthesis and applicationsSynthesis and Biological EvaluationComputational Drug Discovery MethodsMulticomponent Synthesis of Heterocycles

Publications

27

Citations

103

Est. group size

—

Recurring co-author estimate

Active years

18

Publishing since 2009

Research summary
AI-generated

Ekta Verma works in medicinal chemistry, designing and synthesizing new small molecules and testing them for biological activity against diseases. Much of the work focuses on quinolone- and quinazolinone-based compounds as potential treatments for conditions like allergic asthma, cancer, tuberculosis, and microbial infections, combining laboratory synthesis with computational modeling (such as molecular docking and predictions of drug-like properties).

Synthesis of heterocyclic drug candidatesAnticancer and antimicrobial compoundsAntihistaminic and anti-asthma agentsComputational drug design and molecular dockingStructure-activity relationship studies

Publication activity has grown noticeably over the decade, with a marked increase from 2023 onward compared to earlier years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.8/year recently
2017: 1 publication172018: 1 publication182019: 3 publications19202021: 1 publication212022: 1 publication222023: 7 publications7232024: 6 publications242025: 4 publications252026: 1 publication26
Recent publications
Publishes in
  • Nanoscale×2
  • ChemistrySelect×2
  • Zenodo (CERN European Organization for Nuclear Research)×2
  • ACS electrochemistry.×1
  • Central Nervous System Agents in Medicinal Chemistry×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile